These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 377968)

  • 61. Profile of a new low dose combination estrogen and progestogen oral contraceptive: a review of nine clinical studies.
    Woutersz TB
    J Reprod Med; 1975 Sep; 15(3):87-92. PubMed ID: 1214254
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Our experience with the use of the contraceptive preparations Femovan and Triquilar from the Schering firm].
    Milchev N; Terzhumanov R; Grozdanov G; Krumov G
    Akush Ginekol (Sofiia); 1992; 31(2):42-3. PubMed ID: 1342561
    [No Abstract]   [Full Text] [Related]  

  • 63. Venous thromboembolism, myocardial infarction, and stroke among transdermal contraceptive system users.
    Cole JA; Norman H; Doherty M; Walker AM
    Obstet Gynecol; 2007 Feb; 109(2 Pt 1):339-46. PubMed ID: 17267834
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Metabolic effects and efficacy of a triphasic oral contraceptive (norgestimate/ethinyl estradiol).
    Andolsek KM; Burkman RT; Kafrissen ME; Olson W; Osterman J
    Int J Fertil Menopausal Stud; 1993; 38 Suppl 3():122-5. PubMed ID: 8260970
    [No Abstract]   [Full Text] [Related]  

  • 65. 20 mcg versus >20 mcg estrogen combined oral contraceptives for contraception.
    Gallo MF; Nanda K; Grimes DA; Schulz KF
    Cochrane Database Syst Rev; 2005 Apr; (2):CD003989. PubMed ID: 15846690
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Clinical evaluation of two biphasic and one triphasic norgestrel/ethinyl estradiol regimens.
    Larrañaga A; Sartoretto JN; Winterhalter M; Navas Filho F
    Int J Fertil; 1978; 23(3):193-9. PubMed ID: 40893
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Changes in arterial blood pressure of women using hormonal contraceptives in relation to their cardiovascular history].
    Manuilova IA; Dubnitskaia LV; Korsakov SG
    Akush Ginekol (Mosk); 1989 Jul; (7):48-51. PubMed ID: 2478038
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Five-year, multicenter study of a triphasic, low-dose, combination oral contraceptive.
    Woutersz TB; Korba VD
    Int J Fertil; 1988; 33(6):406-10. PubMed ID: 2906915
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Effect of an oral contraceptive (ethinylestradiol/D-norgestrel) on growth hormone and insulin secretion].
    Hausmann L; Goebel KM; Zehner J
    Schweiz Med Wochenschr; 1976 Oct; 106(43):1470-4. PubMed ID: 1013665
    [TBL] [Abstract][Full Text] [Related]  

  • 70. A review of post-marketing safety and surveillance data for oral contraceptives containing norgestimate and ethinyl estradiol.
    Lippman JS; Shangold GA
    Int J Fertil Womens Med; 1997; 42(4):230-9. PubMed ID: 9309456
    [No Abstract]   [Full Text] [Related]  

  • 71. Assessment of incremental dosage regimen of combined oestrogen-progestogen oral contraceptive.
    Brosens IA; Robertson WB; Van Assche FA
    Br Med J; 1974 Dec; 4(5945):643-5. PubMed ID: 4441832
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The contraceptive patch. Latest developments.
    Courtney K
    AWHONN Lifelines; 2006; 10(3):250-4. PubMed ID: 16792714
    [No Abstract]   [Full Text] [Related]  

  • 73. Prescribing an oral contraceptive for the individual woman.
    Chick P
    Aust Fam Physician; 1980 Feb; Suppl():8-12. PubMed ID: 6444808
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Effect of low-dose oral contraceptives on carbohydrate and lipid metabolism in women with recent gestational diabetes: results of a controlled, randomized, prospective study.
    Kjos SL; Shoupe D; Douyan S; Friedman RL; Bernstein GS; Mestman JH; Mishell DR
    Am J Obstet Gynecol; 1990 Dec; 163(6 Pt 1):1822-7. PubMed ID: 2256489
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Oral contraceptives: 30 vs 20 micrograms of ethinyl estradiol (EE)].
    Urdinola J
    Adv Contracept; 1994 Jul; 10 Suppl 1():41-9. PubMed ID: 7839871
    [No Abstract]   [Full Text] [Related]  

  • 76. Psychodiagnostic follow-up of Neovletta -- a new low dose oral contraceptive.
    Fedor-Freybergh P; Hjelmqvist M; Zador G
    Acta Obstet Gynecol Scand Suppl; 1976; 54():77-82. PubMed ID: 1067714
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Divergent effects of a combined hormonal oral contraceptive on insulin sensitivity in lean versus obese women.
    Cheang KI; Essah PA; Sharma S; Wickham EP; Nestler JE
    Fertil Steril; 2011 Aug; 96(2):353-359.e1. PubMed ID: 21676394
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Evra--a patch on oral contraception?
    Drug Ther Bull; 2003 Dec; 41(12):89-91. PubMed ID: 14723093
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Effects of norgestimate (0.250 mg) in combination with ethinyl estradiol (0.035 mg) on cervical mucus.
    Hull ME; Moghissi KS
    Adv Contracept; 1986 Mar; 2(1):71-7. PubMed ID: 3776738
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Alopecia related to low dose oral contraceptive.
    Yokoyama Y; Sato S; Saito Y
    Arch Gynecol Obstet; 2002 Jan; 266(1):46-7. PubMed ID: 11998965
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.